Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley J Porter

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|June 17, 2017
Infectious crystalline keratopathy after Descemet’s stripping endothelial keratoplastyAshley J Porter, Graham A Lee, Kevin Whitehead
Survey of Ophthalmology|November 4, 2017
Infectious crystalline keratopathyAshley J Porter, Graham A Lee, Albert S Jun
BMJ Case Reports|June 6, 2018
Driver's side curtain air bag-related globe ruptureAshley J Porter, Rylan Hayes, Lawrence Lee, et al.
Behavioural Brain Research|November 3, 2015
Differences in the performance of NK1R-/- ('knockout') and wildtype mice in the 5‑Choice Continuous Performance TestAshley J Porter, Katharine Pillidge, S Clare Stanford, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 24, 2015
The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorderAshley J Porter, Katharine Pillidge, Ewelina M Grabowska, et al.
Journal of Psychopharmacology (Oxford, England)|April 22, 2016
Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance TestKatharine Pillidge, Ashley J Porter, Jared W Young, et al.
Pharmacology, Biochemistry, and Behavior|December 3, 2014
Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor 'knockout' miceKatharine Pillidge, Ashley J Porter, Temis Vasili, et al.
Cornea|June 23, 2026
Clinical Outcomes After Weekly Intracameral Melphalan Administration for Epithelial DowngrowthGeraldine Zi Yi Lee, Ljubica Bukorovic, Ashley J Porter, et al.
Eye (London, England)|May 12, 2019
Combined phacoemulsification and microinvasive glaucoma surgery in comparison to phacoemulsification alone for open angle glaucomaGraham A Lee, Ashley J Porter, Roslyn A Vincent, et al.
British Journal of Pharmacology|July 31, 2014
The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHDKatharine Pillidge, Ashley J Porter, Julia A Dudley, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|June 17, 2017
Infectious crystalline keratopathy after Descemet’s stripping endothelial keratoplastyAshley J Porter, Graham A Lee, Kevin Whitehead
Survey of Ophthalmology|November 4, 2017
Infectious crystalline keratopathyAshley J Porter, Graham A Lee, Albert S Jun
BMJ Case Reports|June 6, 2018
Driver's side curtain air bag-related globe ruptureAshley J Porter, Rylan Hayes, Lawrence Lee, et al.
Behavioural Brain Research|November 3, 2015
Differences in the performance of NK1R-/- ('knockout') and wildtype mice in the 5‑Choice Continuous Performance TestAshley J Porter, Katharine Pillidge, S Clare Stanford, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 24, 2015
The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorderAshley J Porter, Katharine Pillidge, Ewelina M Grabowska, et al.
Journal of Psychopharmacology (Oxford, England)|April 22, 2016
Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance TestKatharine Pillidge, Ashley J Porter, Jared W Young, et al.
Pharmacology, Biochemistry, and Behavior|December 3, 2014
Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor 'knockout' miceKatharine Pillidge, Ashley J Porter, Temis Vasili, et al.
Cornea|June 23, 2026
Clinical Outcomes After Weekly Intracameral Melphalan Administration for Epithelial DowngrowthGeraldine Zi Yi Lee, Ljubica Bukorovic, Ashley J Porter, et al.
Eye (London, England)|May 12, 2019
Combined phacoemulsification and microinvasive glaucoma surgery in comparison to phacoemulsification alone for open angle glaucomaGraham A Lee, Ashley J Porter, Roslyn A Vincent, et al.
British Journal of Pharmacology|July 31, 2014
The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHDKatharine Pillidge, Ashley J Porter, Julia A Dudley, et al.
Pageof 1